Cargando…

Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules

Anti-retroviral drugs suppress HIV-1 plasma viremia to undetectable levels; however, latent HIV-1 persists in reservoirs within HIV-1-infected patients. The silent provirus can be activated through the use of drugs, including protein kinase C activators and histone deacetylase inhibitors. This “shoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Jing, Yan, Ming, Liu, Yang, Li, Jie, Xie, Yiming, Lu, Yunfeng, Kamata, Masakazu, Chen, Irvin S. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822841/ https://www.ncbi.nlm.nih.gov/pubmed/27049645 http://dx.doi.org/10.1371/journal.pone.0151572

Ejemplares similares

Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs
por: Yan, Ming, et al.
Publicado: (2015)

A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure
por: Maina, Edward K., et al.
Publicado: (2021)

Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1
por: Khamaikawin, Wannisa, et al.
Publicado: (2017)

Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates
por: Qin, Meng, et al.
Publicado: (2020)

The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure
por: Ranganath, Nischal, et al.
Publicado: (2018)

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
por: Boyer, Zoe, et al.
Publicado: (2018)

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
por: Promsote, Wanwisa, et al.
Publicado: (2023)

Implications of HIV-1 Nef for “Shock and Kill” Strategies to Eliminate Latent Viral Reservoirs
por: Kuang, Xiaomei T., et al.
Publicado: (2018)

The HIV-1 latent reservoir is largely sensitive to circulating T cells
por: Warren, Joanna A, et al.
Publicado: (2020)

Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
por: Rasmussen, Thomas A., et al.
Publicado: (2013)

Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs
por: Kim, Josh G., et al.
Publicado: (2022)

Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection
por: Ho, Ya-Chi, et al.
Publicado: (2015)

Antibody-Enabled Antimicrobial Nanocapsules for Selective Elimination of Staphylococcus aureus
por: Ivanova, Kristina, et al.
Publicado: (2020)

Heterogeneity of HIV-1 latent reservoirs
por: Zhao, Jia-Cong, et al.
Publicado: (2020)

Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs
por: Sadowski, Ivan, et al.
Publicado: (2019)

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection
por: Bai, Ruojing, et al.
Publicado: (2022)

HIV-1 protease-induced apoptosis
por: Rumlová, Michaela, et al.
Publicado: (2014)

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
por: Suryawanshi, Poonam, et al.
Publicado: (2021)

Broad activation of latent HIV-1 in vivo
por: Barton, Kirston, et al.
Publicado: (2016)

HIV-1 latent reservoir: size matters
por: Hodel, Flavia, et al.
Publicado: (2016)

Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein
por: Mótyán, János András, et al.
Publicado: (2021)

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy
por: Mohamed, Hager, et al.
Publicado: (2023)

Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5
por: Shimizu, Saki, et al.
Publicado: (2009)

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
por: Petkov, Stefan, et al.
Publicado: (2022)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

The evolution of the HIV-1 protease folding stability
por: Ferreiro, David, et al.
Publicado: (2022)

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
por: Lee, Wen Shi, et al.
Publicado: (2015)

Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+ T-Cells
por: Kamata, Masakazu, et al.
Publicado: (2009)

The reservoir of latent HIV
por: Chen, Jing, et al.
Publicado: (2022)

The host cell side of latent HIV-1 infection
por: Seu, Lillian, et al.
Publicado: (2015)

Establishment and stability of the latent HIV-1 DNA reservoir
por: Brodin, Johanna, et al.
Publicado: (2016)

The Potential Contribution of Caveolin 1 to HIV Latent Infection
por: Sahay, Bikash, et al.
Publicado: (2020)

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
por: Nakashima, Masaaki, et al.
Publicado: (2016)

Whiskers-less HIV-protease: a possible way for HIV-1 deactivation
por: Dayer, Mohammad Reza, et al.
Publicado: (2013)

Humanized Mice for Studies of HIV-1 Persistence and Elimination
por: Zhang, Chen, et al.
Publicado: (2023)

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
por: Verdikt, Roxane, et al.
Publicado: (2022)

HIV-1 Protease: Structural Perspectives on Drug Resistance
por: Weber, Irene T., et al.
Publicado: (2009)

Molecular Basis for Drug Resistance in HIV-1 Protease
por: Ali, Akbar, et al.
Publicado: (2010)

Dynamical Basis for Drug Resistance of HIV-1 Protease
por: Mao, Yi
Publicado: (2011)

HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe
por: Benko, Zsigmond, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_63loovergklp25jo414fev0oho